Peer Review History
| Original SubmissionAugust 7, 2025 |
|---|
|
Dear Dr. Tran, plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Iman Al-Saleh Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: “This study was supported by the National Project “Development of a Basic Biochemical Index Set for Environmental Toxicology in the Vietnamese Working-Age Population” (Project code: ĐTĐL.CN-39/21), under the Basic Science Development Program in Chemistry, Life Sciences, Earth Sciences, and Marine Sciences (2017–2025) funded by the Ministry of Science and Technology. The authors gratefully acknowledge this valuable support” We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “SVN received the funding from the Ministry of Science and Technology as a principle investigator of the National Project “Development of a Basic Biochemical Index Set for Environmental Toxicology in the Vietnamese Working-Age Population” (Project code: ĐTĐL.CN-39/21) under the Basic Science Development Program in Chemistry, Life Sciences, Earth Sciences, and Marine Sciences (2017–2025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** Reviewer #1: This study presents a nationwide analysis of urinary cotinine as a biomarker for exposure to tobacco smoke (nicotine). The study itself is not novel. Surveys on tobacco smoke exposure are routinely conducted in various countries, including the USA, Brazil, Korea, and Japan. However, the introduction of a cut-point for urinary cotinine levels, adjusted for creatinine concentration, adds valuable insight to the literature. Overall, the study is well-executed, with data processed through robust statistical analysis, yielding reliable results. Here are some suggestions for enhancing this work: 1. The urinary cotinine concentrations for active and passive smokers in this study should be compared with those in other global studies, and any differences should be discussed. Please review additional literature on this topic. The reviewer can suggest a few as follows, sorted by publication year: - 2022: https://doi.org/10.3390/ijerph19063746 - 2021: https://doi.org/10.1186/s12889-021-11265-y - 2021: https://doi.org/10.4082/kjfm.20.0056 - 2020: http://dx.doi.org/10.2174/1875318302010010060 - 2020: https://doi.org/10.21215/kjfp.2020.10.5.378 - 2019: https://doi.org/10.1080/1354750X.2019.1684563 - 2019: https://doi.org/10.1080/1354750X.2020.1797879 2. Similarly, the proposed cut-point should be compared with those suggested in other studies. In several studies, the cut-point for urinary cotinine is suggested to range from 30 to 40 µg/g-creatinine. Please review additional literature on this topic. The reviewer can suggest a few as follows, sorted by publication year: - 2022: https://doi.org/10.3390/ijerph19063746 - 2020: https://doi.org/10.3390/ijerph17155537 - 2016: https://doi.org/10.3390/ijerph13121236 3. Surprisingly, the survey does not inquire about the types of cigarettes regularly smoked by participants. With the increasing prevalence of vaping, there may be greater nicotine exposure compared to conventional smoking. This is a significant limitation and should be discussed comprehensively. 4. Please provide QA/QC information for the analysis. Reviewer #2:Dear Authors, Thank you for submitting your manuscript to PLOS ONE. In your statistical analysis (lines 215, 216, and 217), please specify the exact outlier detection test you used. For example, did you use the Grubbs test (https://www.graphpad.com/quickcalcs/) for continuous data? If so, please indicate this clearly and, if desired, provide the reference. At the end of line 236, ensure you include the confidence interval used (e.g., 95%), as this information is essential. For Figure 1, please indicate the sensitivity and specificity test values, alongside the CCR cut-off value, within the figure or its legend, as the cut-off selection in the ROC curve depends on these metrics. I hope these minor suggestions will assist you in improving the manuscript. Reviewer #3: This manuscript describes the first nation-wide study to monitor smoking prevalence and exposure to second hand smoke in Vietnam. So far, most studies in Vietnam and developing countries only used questionnaires to record and estimate prevalence, thus the data are of great interest to public health agencies and could serve as evidence for future tobacco control policies. The authors have presented all the data, with unexpected findings such as lower smoking prevalence in farmers and lower income earners than official and high income earners. However, I suggest the authors to consider some issues below: 1. The recruitment process has to be described in detail to show that the sampled populations are representative. 2. The justification of spot urine is not correct in my opinion. First void samples will probably give more consistency and be complemented by the questionnaires about how many cigarettes you smoked yesterday 3. I am not an expert in statistics but I wonder whether the unexpected findings such as the low prevalence in farmers and high prevalence in Ho Chi Minh city have anything to do with the power of the data (i.e. the sample size at provincial level is small and thus prone to high uncertainty). 4. The data about female smoking prevalence is also interesting as people usually assume very low level of smoking in female in Asia in general. Question to the authors is that whether the relatively high prevalence in female is due to the “false positive” diagnosis using the CCR of 21 (I don’t think you need to be super accurate with 3 significant figures). 5. Similarly, the discussion about under-reporting of smoking status, my layman understanding is that the research team, not only of this study but all studies, would have had to declare in the Participant Information Sheet that they would analyse the urine samples for tobacco biomarkers. Therefore, it would be a real surprise if the participants still tried to hide their smoking status in the questionnaires. To me, it may well be the effect of the artificial CCR values. 6. If possible, try to present the data in figures rather than table form. 7. If possible, please compile a range of CCR values from different studies. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Ricardo David Couto, Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Bahia, Brazil. Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Urinary Cotinine concentration as a biomarker of environmental exposure to Nicotine in Vietnam: Results from a Nationwide Survey in 2024 PONE-D-25-38585R1 Dear Dr. Tran, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Iman Al-Saleh Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: The presented responses were thoughtful, and the manuscript is well-revised. The reviewer has no further comments. Congratulations to the authors for running such a meaningful survey. Reviewer #2: (No Response) Reviewer #3: the authors have addressed the comments adequately although I feel the title and the conclusion are not well aligned, please consider revise the title. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Ricardo David Couto Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-25-38585R1 PLOS One Dear Dr. Tran, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Iman Al-Saleh Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .